Skip to content

Acute Pharmacological Effects of 2C-B in Humans: An Observational Study

Esther Papaseit, Marta Torrens, Mireia Ventura, Mitona Pujadas, Débora González, Magı́ Farré, Clara Pérez‐mañá, Rafael de la Torre

Frontiers in Pharmacology March 13, 2018 DOI: 10.3389/fphar.2018.00206 via OpenAlex

Summary

AI-generated from the abstract

2C-B, a psychedelic similar to mescaline, acts on serotonin receptors and produces mild psychedelic and stimulant-like effects. In an observational study, 16 healthy experienced users took 10–20 mg orally. The drug increased blood pressure and heart rate, elevated scores on scales for euphoria, liking, and stimulation, and altered perceptions of distances, colors, shapes, and lights. Five participants reported mild hallucinations. Peak 2C-B levels in saliva occurred at 1 hour, and peak cortisol at 3 hours. The effects resemble those of other serotonin-acting drugs.

Study at a glance

Characteristics Observational study Peer reviewed
Sample size 16
Population Healthy, experienced drug users
Intervention 2C-B
Dose 10, 15, or 20 mg
Duration 6 hours for subjective and physiological effects; 24 hours for pharmacokinetics
Topics Mescaline
Keywords Euphoriant Heart rate Hallucinogen Visual analogue scale
Citations 61
Key finding Oral 2C-B at recreational doses increases blood pressure and heart rate, produces euphoria and perceptual changes, and induces mild hallucinating effects in some users.

Abstract

2,5-dimethoxy-4-bromophenethylamine (2C-B) is a psychedelic phenylethylamine derivative, structurally similar to mescaline. It is a serotonin 5-hydroxytryptamine-2A (5-HT2A), 5-hydroxytryptamine-2B (5-HT2B), and 5-hydroxytryptamine-2C (5-HT2C) receptor partial agonist used recreationally as a new psychoactive substance. It has been reported that 2C-B induces mild psychedelic effects, although its acute pharmacological effects and pharmacokinetics have not yet been fully studied in humans. An observational study was conducted to assess the acute subjective and physiological effects, as well as pharmacokinetics of 2C-B. Sixteen healthy, experienced drug users self-administered an oral dose of 2C-B (10, 15, or 20 mg). Vital signs (blood pressure and heart rate) were measured at baseline 1, 2, 3, 4, and 6 hours (h). Each participant completed subjective effects using three rating scales: the visual analog scale (VAS), the Addiction Research Centre Inventory (ARCI), and the Evaluation of the Subjective Effects of Substances with Abuse Potential (VESSPA-SSE) at baseline, 2-3 and 6 h after self-administration (maximum effects along 6 h), and the Hallucinogenic Rating Scale (maximum effects along 6 h). Oral fluid (saliva) was collected to assess 2C-B and cortisol concentrations during 24 h. Acute administration of 2C-B increased blood pressure and heart rate. Scores of scales related to euphoria increased (high, liking, and stimulated), and changes in perceptions (distances, colors, shapes, and lights) and different body feelings/surrounding were produced. Mild hallucinating effects were described in five subjects. Maximum concentrations of 2C-B and cortisol were reached at 1 and 3 h after self-administration, respectively. Oral 2C-B at recreational doses induces a constellation of psychedelic/psychostimulant-like effects similar to those associated with serotonin-acting drugs.

Explore topics

Comments

No comments yet.

Log in to comment